Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Dear Sirs, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose Notice of Postal Ballot dated April 13, 2022, being sent through e-mail to the Shareholders of the Company for seeking their approval by way of Special Resolution for Alteration of Articles of Association. The e-voting will commence on Sunday, April 17, 2022 at 9:00 am and will end on Monday, May 16, 2022 at 5:00 pm. This is for your information and record.
16-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue letter of confirmation to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
13-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we certify that M/s Alankit Assignments Limited, a Category-I Registrar and Share Transfer Agent, registered with the Securities and Exchange Board of India vide Registration No.: INR000002532, is the Registrar and Share Transfer Agent (the 'RTA') of Jubilant Pharmova Limited (the 'Company') and all activities in relation to both physical and electronic share transfer facility of the Company are being maintained by the RTA.
12-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are enclosing a Confirmation Certificate for the quarter ended March 31, 2022 received from M/s Alankit Assignments Limited, Registrar and Share Transfer Agent of the Company. We request you to take the same on record.
12-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue letter of confirmation to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
09-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sirs, Sub.: Update on Investors/ Analysts Meeting In continuation to our letter dated April 4, 2022 intimating our intention to attend Group Meeting on April 5, 2022, we wish to intimate that the said meeting has been cancelled due to exigencies on the part of Investor/ Company. We request you to take the same on record.
05-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be attending Group Meeting on April 5, 2022. We enclose details of the Investors/ Analysts for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the Virtual Meet.
04-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Acquisition

 Pursuant to the provisions of Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that subject to applicable laws, the Company has entered into Share Purchase Agreement, and Share Subscription and Shareholders Agreement on April 1, 2022 for acquiring equity and preference shares of SPV Laboratories Private Limited ('Greencure'). Relevant details are given in Annexure-A to this letter. We request you to take the same on record.
02-04-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be organising Virtual Meeting on March 31, 2022. We enclose details of the Investors/ Analysts for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the Virtual Meet.
30-03-2022
Bigul

Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. We propose to issue Letter of Confirmation to the shareholder on receipt of the requisite documents. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
24-03-2022
Next Page
Close

Let's Open Free Demat Account